Skip to main content
. 2019 Mar 18;8(3):380. doi: 10.3390/jcm8030380

Figure 2.

Figure 2

Evaluation of CD4 and CD8 T cells in responding (R) and nonresponding (N-R) patients of the bevacizumab-treated group and the control group by cytofluorimetry. CD8 T cells were identified by gating the CD3+CD8+ cells, while the CD4 T cells were identified as CD3+CD8.